Severe and life‐threatening COVID‐19‐related mucocutaneous eruptions: A systematic review
Open Access
- 19 August 2021
- journal article
- review article
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 75 (12) , e14720
Abstract
Objectives Earlier diagnosis and the best management of virus-related, drug-related or mixed severe potentially life-threatening mucocutaneous reactions of COVID-19 patients are of great concern. These patients, especially hospitalized cases, are usually in a complicated situation (due to multi-organ failures), which makes their management more challenging. In such consultant cases, achieving by the definite beneficial management strategies that therapeutically address all concurrent comorbidities are really hard to reach or even frequently impossible. Methods According to the lack of any relevant systematic review, we thoroughly searched the databases until October/5/2020and finally found 57 articles including 93 patients. It is needed to know clinical presentations of these severe skin eruptions, signs and symptoms of COVID in these patients, time of skin rash appearance, classifying drug-related or virus-related skin lesions, classifying the type of skin rash, patients’ outcome and concurrent both COVID-19 therapy and skin rash treatment. Result Severe and potential life-threatening mucocutaneous dermatologic manifestations of COVID-19 usually may be divided into three major categories: virus-associated, drug-associated, and those with uncertainty about the exact origin. Angioedema, vascular lesions, toxic shock syndrome, erythroderma, DRESS, hemorrhagic bulla, AGEP, EM, SJS and TEN, generalized pustular figurate erythema were the main entities found as severe dermatologic reactions in all categories. Conclusion We can conclude vascular injuries may be the most common cause of severe dermatologic manifestations of COVID-19, which is concordant with many proposed hypercoagulation tendency and systemic inflammatory response syndrome as one of the most important pathomechanism of COVID-19so the skin may show these features in various presentations and degrees.Keywords
This publication has 79 references indexed in Scilit:
- Big data and cutaneous manifestations of COVID-19Journal of the American Academy of Dermatology, 2020
- Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five casesTranslational Research, 2020
- Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID‐19 eraDermatologic Therapy, 2020
- The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the statusMilitary Medical Research, 2020
- A Unique Case Report on Hypersensitivity Vasculitis as an Allergic Reaction to the Herpes Zoster VaccineVascular and Endovascular Surgery, 2018
- The Evaluation and Management of Toxic Shock Syndrome in the Emergency Department: A Review of the LiteratureThe Journal of Emergency Medicine, 2018
- Treatments for Severe Cutaneous Adverse ReactionsJournal of Immunology Research, 2017
- Life-threatening severe allergic reactions: urticaria, angioedema, and anaphylaxisClinics in Dermatology, 2005
- Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndromeArchives of Disease in Childhood, 2000
- Severe erythrodermic reactions to the proton pump inhibitors omeprazole and lansoprazoleBritish Journal of Dermatology, 1999